Jazz Pharmaceuticals plc Accumulated Other Comprehensive Income
Jazz Pharmaceuticals plc (JAZZ) had Accumulated Other Comprehensive Income of -$662.50 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-03
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$662.50M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$651.00M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$568.60M; Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed -$568.60M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$569.90M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$662.50M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | -$651.00M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | -$568.60M 10-Q · filed 2026-08-03 | -$568.60M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$569.90M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | -$485.77M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | -$785.61M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | -$947.67M 10-K · filed 2026-02-24 | |
| 2024-09-30 | -$603.40M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$888.23M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | -$882.39M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | -$842.15M 10-K · filed 2025-02-26 | |
| 2023-09-30 | -$1.04B 10-Q · filed 2023-11-08 | |
| 2023-06-30 | -$866.82M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$980.23M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$1.13B 10-K · filed 2024-02-28 | |
| 2022-09-30 | -$1.62B 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$1.11B 10-Q · filed 2022-08-03 | |
| 2022-03-31 | -$590.72M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | -$400.36M 10-K · filed 2023-03-01 | |
| 2021-09-30 | -$397.52M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$190.94M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | -$179.43M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | -$134.35M 10-K · filed 2022-03-01 | |
| 2020-09-30 | -$187.80M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | -$236.11M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | -$257.44M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | -$223.39M 10-K · filed 2021-02-23 | |
| 2019-09-30 | -$259.44M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | -$210.44M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | -$220.67M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | -$197.79M 10-K · filed 2020-02-25 | |
| 2018-09-30 | -$179.47M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | -$168.23M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | -$98.77M 10-Q · filed 2018-05-08 | |
| 2018-01-01 | -$140.82M 10-K · filed 2019-02-26 | |
| 2017-12-31 | -$140.88M 10-K · filed 2019-02-26 | |
| 2017-09-30 | -$158.99M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$210.25M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$299.84M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$317.33M 10-K · filed 2018-02-27 | |
| 2016-09-30 | -$235.38M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | -$249.99M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$222.28M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$267.47M 10-K · filed 2017-02-28 | |
| 2015-09-30 | -$231.28M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$248.04M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | -$278.58M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$122.10M 10-K · filed 2016-02-23 | |
| 2014-09-30 | -$57.13M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $59.95M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $70.89M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $56.15M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $44.62M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $19.22M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $10.61M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $31.05M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $13.86M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | -$388.00K 10-Q · filed 2012-08-07 | |
| 2011-12-31 | -$31.00K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |